Yoshio Sumida

发表

Current and new pharmacotherapy options for non-alcoholic steatohepatitis

T. Okanoue, A. Nakajima, M. Yoneda, 2020, Expert opinion on pharmacotherapy.

Characteristics of Lung Cancer Cases Detected by Mass Survey and Some Problems Involved in Lung Cancer Screening in Tsuna-gun, Hyogo-Ken

Yasuharu Takashima, Tokutaro Tanaka, Yoshio Sumida, 1997 .

A nutritional intervention that promotes increased vegetable intake in Japanese with non-alcoholic fatty liver disease: a six-month trial

Y. Naito, Yukiko Kobayashi, W. Aoi, 2021, Journal of clinical biochemistry and nutrition.

A 3-step approach to predict advanced fibrosis in nonalcoholic fatty liver disease: impact on diagnosis, patient burden, and medical costs

Hirokazu Takahashi, M. Yoneda, S. Saito, 2022, Scientific Reports.

Low-dose PEG-IFNα2a maintenance therapy significantly reduces serum levels of ALT and AFP in chronic hepatitis C patients compared to glycyrrhizin

T. Sando, H. Oyamada, S. Katsushima, 2011 .

A low‐intensity 10‐min resistance exercise program that ameliorated hepatic fibrosis indices and altered G‐CSF/IP‐10/PDGF‐BB in a patient with nonalcoholic fatty liver disease: A case report

T. Kawaguchi, Sachiyo Yoshio, T. Kanto, 2023, JGH open : an open access journal of gastroenterology and hepatology.

Association of Serum Albumin Levels and Long-Term Prognosis in Patients with Biopsy-Confirmed Nonalcoholic Fatty Liver Disease

T. Kawaguchi, T. Okanoue, A. Morishita, 2023, Nutrients.

Prediction of Liver-Related Events With a Combination of Liver Stiffness Measurements and Controlled Attenuation Parameters in Japanese Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease.

T. Kawaguchi, T. Okanoue, S. Aishima, 2023, Ultrasound in medicine & biology.

Identification of clinical phenotypes associated with poor prognosis in patients with nonalcoholic fatty liver disease via unsupervised machine learning.

T. Kawaguchi, T. Okanoue, A. Morishita, 2023, Journal of gastroenterology and hepatology.

Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large‐scale multicenter retrospective study

H. Yoshiji, N. Enomoto, T. Kawaguchi, 2023, Hepatology research : the official journal of the Japan Society of Hepatology.

Agile 3+ and Agile 4, noninvasive tests for liver fibrosis, are excellent formulae to predict liver‐related events in nonalcoholic fatty liver disease

T. Kawaguchi, T. Okanoue, Kouichi Miura, 2023, Hepatology research : the official journal of the Japan Society of Hepatology.